We are live on ! Find out more
CEROW

CERo Therapeutics Warrants

Delisted

CEROW was delisted on the 30th of October, 2025.

23 hedge funds and large institutions have $74.5K invested in CERo Therapeutics Warrants in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more capital invested

Capital invested by funds: $45.7K → $74.5K (+$28.9K)

32.65% more ownership

Funds ownership: 2.26%34.91% (+33%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

12% less funds holding

Funds holding: 2623 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
6
Calls
$3K
Puts
Net Calls
+$3K
Net Calls Change
+$1K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
26
Rivernorth Capital Management
Florida
-$362 -24,998 Closed
SSA
27
Schonfeld Strategic Advisors
New York
-$217 -15,000 Closed
Walleye Trading
28
Walleye Trading
New York
-$193 -13,333 Closed
VF
29
Virtu Financial
New York
+$317 +20,474 New

CEROW Hedge Fund Activity: Q2 2025 in Review

23 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q2 2025, worth a combined $74.5K — up 63% from $45.7K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CEROW and 3 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $5.91K. The largest seller was Periscope Capital, exiting entirely with an estimated $3.97K sold.

  • 23 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q2 2025, down from 26 in Q1 2025.
  • Funds reported $74.5K of CERo Therapeutics Warrants stock for Q2 2025, up 63% quarter-over-quarter.
  • 3 funds opened new CERo Therapeutics Warrants positions in Q2 2025 and 6 closed out, a net change of -3 holders.
  • The largest CERo Therapeutics Warrants buyer in Q2 2025 was Toronto Dominion Bank, an estimated $5.91K added.
  • The largest CERo Therapeutics Warrants seller in Q2 2025 was Periscope Capital, an estimated $3.97K sold.

Based on aggregated 13F filings for Q2 2025.